Neurological symptoms, not signs, are common in early hiv infection

Journal of Neuro-AIDS

Volumn 1, Issue 2, 1996, Pages 67-85

  Mehta, P ^a   Olichney, J M ^a   Gulevich, S J ^a   Thal, L J ^b   Jin, H ^a   McCutchan, J A ^a   Kaplanski, G ^a   Heaton, R K ^c   Kirson, D ^c   Nelson, J ^c   Atkinson, J H ^c   Wallace, M R ^c   Grant, I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NAVAL HOSPITAL   (United States)

^d HIV Neurobehavioral Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; MUSCLE STRENGTH; RISK ASSESSMENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; NEUROPSYCHOLOGICAL TEST;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS;

EID: 0029783696     PISSN: 10697438     EISSN: None     Source Type: Journal    
DOI: 10.1300/J128v01n02_05     Document Type: Article

References (23)

1. Andersson MA, Bergstrom TB, Blomstrand C, Hermodsson SH, Hakansson C, and Lowhagan GE. Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection. J Neuroimmun 1988; 19:291-304.
2. Brew BJ, Bhalla RB, Fleisher M, et al. Cerebrospinal fluid P2 microglobulin in patients infected with human immunodeficiency virus. Neurology 1989; 39:830-834.
3. Davis LE. Neurosyphilis in the patient infected with human immunodeficiency virus. Ann Neurol 1990; 27 (2):211-212.
4. Ensoli B, Lusso P, Schachter F, et al. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. The Embo J 1989; 8 (10):3019-3027.
5. Giorgi JV, Cheng HL, Margolick JB, et al. Quality control in the flow cytometric measurement of lymphocyte-T subsets in the Multicenter AIDS Cohort Study experience. Clin Immunol Immunopathol 1990; 55:173-186.
6. Gotuzzo E, Escamilla J, Phillips IA, Sanchez J, Wignall FS, and Antigoni J. The impact of human T-lymphotropic virus type I/I I infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome. Arch Intern Med 1992; 152:1429-1432.
7. Haas JS, Bolan G, Larsen SA, et al. Sensitivity of treponemal tests for detecting prior-treated syphilis during human immunodeficiency virus infection. J Infect Dis 1990; 162:862-866.
8. Hicks CB, Benson PM, Lupton G, and Tramont EC. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi’s sarcoma: a diagnostic dilemma. Ann Intern Med 1987; 107:492-495.
9. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985; 313:1493-1497.
10. Hook, EW and Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326(16): 1060-1069.
11. Hutchinson CM, Hook EW, Shepherd MS, Verley J, and Rompalo AM. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994; 121:94-99.
12. Johns DR, Tierney M, and Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987; 316(25): 1569-1572.
13. Larsen SA, Hunter EF, Kraus SJ, and Whittington W.I. Diagnostic tests. In: Larsen SA, Hunter EF, Kraus SJ, eds. Manual of tests for syphilis. American Public Health Association, 1990.
14. Lukehart SA, Hook EW, Baker-Zander SA, Collier AC, Critchlow CW, and Hands-Field HH. Invasion of the central nervous system by treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med 1988; 855-862.
15. Machin D and Campbell MJ. Statistical tables for the design of clinical trials. Blackwell, 1987; 38.
16. Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Am Intern Med 1993; 119:185-193.
17. McArthur JC, Cohen BA, Farzadegan H, et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988;23:34-37.
18. Musher DM, Hamill RJ, and Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Int Med 1990; 113 (11):872-881.
19. Rompalo AM, Cannon RO, Quinn TC, and Hook EW. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis 1992; 165:1124-1126.
20. Royal W, Updike M, Seines OA, et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991; 41:1905-1910.
21. Royal W, Seines OA, Concha MD, Nance-Sproson TE, and McArthur JC. Cerebrospinal fluid human immunodeficiency virus type I (HIV-1) p 24 antigen levels in HIV-1 related dementia. Ann Neurol 1994; 36:32-39.
22. Tseng CK, Hughes MA, Hsu PL, Mahoney S, Duvic M, and Sell S. Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits. Am J Path 1991; 138(5): 1149-1164.
23. Webster A. Cytomegalovirus as a possible cofactor in HIV disease progression. J Acquir Immune Defic Syndr 1991; 4:S47-S52.